Resources

Publications

05/26/2023
- Oncology
Analysis on Real-World Chemotherapy Outcomes in Patients (Pts) With Tyrosine Kinase Inhibitor (TKI) Resistant Advanced EGFR-Mutant Non–Small-Cell Lung Cancer (NSCLC) in the United States
ASCO 2023
05/26/2023
- Oncology
Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Patients With De Novo Advanced or Metastatic (Stage IIIB–IV) Non-Small Cell Lung Cancer in a Real-World Setting
ASCO 2023
05/26/2023
- Oncology
Genomic Characterization of Vulvar Squamous Cell Carcinoma To Reveal Differential Gene Expression Based on Clinical Outcome
ASCO 2023
05/26/2023
- Oncology
Identification of a Novel Class of Early Exon ALK Rearrangements Across Two Pan Tumor Sequencing Databases
ASCO 2023
05/26/2023
- Oncology
Association of Molecular Profiles of Head and Neck Squamous Cell Carcinoma With Heterogeneity Across Racial/Ethnic Groups in the United States
ASCO 2023
05/26/2023
- Oncology
Homologous Recombination Deficiency (HRD) in Non-Small Cell Lung Cancer: Genomic Analysis Using an RNA-Based HRD Algorithm
ASCO 2023
05/26/2023
- Oncology
Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer Populations
ASCO 2023
05/26/2023
- Oncology
Molecular Diagnostic Classification for Cancers of Unknown Primary (CUP): Post-Testing Diagnosis and Treatment Impact Analysis From Real-World Claims Data
ASCO 2023
05/26/2023
- Oncology
Real-World Outcomes of First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy in KRAS G12C Altered NSCLC According to PD-L1 Status
ASCO 2023
05/26/2023
- Oncology
Associations Between Androgen-Directed Treatments and AR Mutational Landscapes in the Circulating Tumor DNA of a Real-World Metastatic Prostate Cancer Cohort
ASCO 2023

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69